Literature DB >> 15903147

Compromised arterial oxygen saturation in elderly asthma sufferers results in selective cognitive impairment.

Mark Moss1, Mark Franks, Pamela Briggs, David Kennedy, Andrew Scholey.   

Abstract

Forty elderly patients with asthma or chronic obstructive pulmonary disorder (COPD) were compared to a comparison group of forty age-matched healthy volunteers on a range of measures of cognitive performance, and levels of arterial haemoglobin oxygen saturation recorded. Members of the patient group were found to have significantly lower oxygen saturation compared to the comparison group, and performed significantly poorer on tests of delayed word recall and serial subtractions, but not on other tasks. Correlational analysis between participants' oxygen saturation levels and test scores across the whole sample indicated significant positive relationships existed for the digit symbol substitution and serial subtractions tasks. The results are discussed in terms of cerebral oxygen delivery, glucose metabolism, age related cognitive decline, and relative task demands.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15903147     DOI: 10.1080/13803390490515450

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  9 in total

1.  Asthma control and cognitive function in a cohort of elderly adults.

Authors:  Maile Ray; Mary Sano; Juan P Wisnivesky; Michael S Wolf; Alex D Federman
Journal:  J Am Geriatr Soc       Date:  2015-04-08       Impact factor: 5.562

2.  COPD and cognitive impairment: the role of hypoxemia and oxygen therapy.

Authors:  Neeta Thakur; Paul D Blanc; Laura J Julian; Edward H Yelin; Patricia P Katz; Stephen Sidney; Carlos Iribarren; Mark D Eisner
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-09-07

3.  Relationship of subjective cognitive impairment and cognitive impairment no dementia to chronic disease and multimorbidity in a nation-wide twin study.

Authors:  Barbara Caracciolo; Margaret Gatz; Weili Xu; Alessandra Marengoni; Nancy L Pedersen; Laura Fratiglioni
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

4.  Chronic Respiratory Disease and Cognitive Impairment in Older Mexican Adults.

Authors:  Sreenivas P Veeranki; Brian Downer; Daniel Jupiter; Yong-Fang Kuo; Mukaila Raji; William Calhoun; Rebeca Wong
Journal:  Neurol India       Date:  2019 Nov-Dec       Impact factor: 1.663

5.  Prevalence of Cognitive Impairment in Recently Diagnosed Type 2 Diabetes Patients: Are Chronic Inflammatory Diseases Responsible for Cognitive Decline?

Authors:  Pilar Lavielle; Juan O Talavera; Nancy Reynoso; Marissa González; Rita A Gómez-Díaz; Miguel Cruz; Felipe Vázquez; Niels H Wacher
Journal:  PLoS One       Date:  2015-10-30       Impact factor: 3.240

Review 6.  Recognition, diagnosis, and treatment of cognitive and psychiatric disorders in patients with COPD.

Authors:  Daniel R Ouellette; Kim L Lavoie
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-02-16

7.  Prospective cohort study of pregnancy complications and birth outcomes in women with asthma.

Authors:  Nasrin Fazel; Michael Kundi; Erika Jensen-Jarolim; Isabella Pali-Schöll; Asghar Kazemzadeh; Mojtaba Fattahi Abdizadeh; Habibollah Esmaily; Roya Akbarzadeh; Raheleh Ahmadi
Journal:  Arch Gynecol Obstet       Date:  2018-05-24       Impact factor: 2.344

8.  Masters or pawns? Examining injury and chronic disease in male Masters Athletes and chess players compared to population norms from the Canadian Community Health Survey.

Authors:  Shruti Patelia; Rachael C Stone; Rona El-Bakri; Mehrnaz Adli; Joseph Baker
Journal:  Eur Rev Aging Phys Act       Date:  2018-11-30       Impact factor: 3.878

9.  Effects of Cardiorespiratory Exercise on Cognition in Older Women Exposed to Air Pollution.

Authors:  Edgardo Molina-Sotomayor; Marcelo González Orb; Francisco Pradas de la Fuente; Giovanni Carozzi Figueroa; Antonio Jesús Sánchez-Oliver; José Antonio González-Jurado
Journal:  Int J Environ Res Public Health       Date:  2019-01-16       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.